<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter" xml:lang="EN">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title>Emerging Infectious Diseases</journal-title>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18439384</article-id>
      <article-id pub-id-type="pmc">2600265</article-id>
      <article-id pub-id-type="publisher-id">07-1459</article-id>
      <article-id pub-id-type="doi">10.3201/eid1405.071459</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Persistent Human Metapneumovirus Infection in Immunocompromised Child</article-title>
        <alt-title alt-title-type="running-head">Human Metapneumovirus Infection in Immunocompromised Child</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Abed</surname>
            <given-names>Yacine</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Boivin</surname>
            <given-names>Guy</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <aff id="aff1"><label>*</label>Centre Hospitalier Universitaire de Qu&#xE9;bec, Quebec City, Quebec, Canada</aff>
        <aff id="aff2"><label>&#x2020;</label>Infectious Disease Research Centre, Quebec City, Quebec, Canada</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Guy Boivin, Research Center in Infectious Diseases, Centre Hospitalier Universitaire de Qu&#xE9;bec&#x2013;Centre Hospitalier Universit&#xE9; Laval, Rm RC-709, 2705 Laurier Blvd, Quebec City, QC, Canada G1V 4G2; email: <email xlink:href="guy.boivin@crchul.ulaval.ca">guy.boivin@crchul.ulaval.ca</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2008</year>
      </pub-date>
      <volume>14</volume>
      <issue>5</issue>
      <fpage>854</fpage>
      <lpage>856</lpage>
      <kwd-group kwd-group-type="author" xml:lang="EN">
        <title>Keywords: </title>
        <kwd>Human metapneumovirus</kwd>
        <kwd>hMPV</kwd>
        <kwd>persistence</kwd>
        <kwd>G gene</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Respiratory viral infections can be associated with a wide range of clinical manifestations from self-limiting upper respiratory tract diseases to pneumonia (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). However, in general, respiratory viral infections are more likely to progress to more severe diseases in immmunocompromised patients. Human metapneumovirus (hMPV) has been reported in most parts of the world as a cause of acute respiratory tract infections in persons of all age groups (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Fatal hMPV infections have been reported in immunocompromised patients, including a 17-month-old girl who had acute lymphoblastic leukemia (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>) and a 33-year-old woman who had received a hematopoietic stem cell transplant (HSCT) (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). In adult HSCT recipients, fatal pneumonia (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>) and persistent hMPV infection without respiratory symptoms have been described (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>). In addition, adult lung transplant recipients have been able to clear hMPV infection despite high levels of immunosuppression (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>). We report a case of persistent hMPV infection in a child with severe combined immunodeficiency disorder (SCID) who shed hMPV during an 11-month period.</p>
    <p>The child, a girl who was born in January 2002, received an allogeneic haploidentical stem cell transplant from her father in May 2002 after her diagnosis of SCID. Infection with influenza A virus (H3N2) was diagnosed on April 2005 and progressed to a chronic pneumonitis of the lingula. She received successive courses of anti-influenza agents (amantadine, oseltamivir, and zanamivir) for 1 year during which time several positive influenza cultures were obtained (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). Four years after the transplant, she was still lymphopenic (800 &#xD7; 10<sup>9</sup>/L, mostly T cells) and had chronic graft-versus-host disease, which had been treated with steroids (prednisone 2.5 mg twice a day for many months). She also had a mild chronic cough but did not need supplemental oxygen while she was receiving nebulized zanamivir (10&#x2013;20 mg twice a day). Her 2 nasopharyngeal aspirate (NPA) specimens from June and July 2006 were negative for influenza virus. However, positive cultures for hMPV were obtained from NPA and bronchoalveolar lavage specimens collected on July 2006. After receiving this result, we performed retrospective and prospective molecular detection studies for hMPV for this patient. HMPV was detected by reverse transcription&#x2013;PCR for the F and G genes (<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>) in 6 and 7 NPA samples, respectively, collected during an 11-month period from November 4, 2005, through October 4, 2006. These samples were obtained for surveillance of influenza infection in this child with persistent cough.</p>
    <p>Amplified hMPV G sequences were aligned by using the ClustalW program (<ext-link ext-link-type="uri" xlink:href="http://www.molecularevolution.org/cdc/software/clustalw">www.molecularevolution.org/cdc/software/clustalw</ext-link>). A phylogenetic tree was constructed with MEGA 3.1 software (<ext-link ext-link-type="uri" xlink:href="http://www.megasoftware.net">www.megasoftware.net</ext-link>) by using the neighbor-joining algorithm with Kimura-2 parameters. Sequence analysis of the hMPV G gene showed that all strains belonged to the B2 genotype, which clustered with hMPV Can98&#x2013;75 and NL1/94 reference strains (<xref ref-type="fig" rid="F1">Figure</xref>, <bold>panel A</bold>). Amplified hMPV G gene sequences of the 6 samples collected in 2006 were identical, but they had 96.7% and 92.8% nucleotide and amino acid identities, respectively, with the initial strain from November 2005, which clearly indicates 2 viral strains (<xref ref-type="fig" rid="F1">Figure</xref>, <bold>panel B</bold>). Similar results were obtained with the F gene (data not shown). Inoculation of the respiratory samples on a panel of 10 cell lines as previously described (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>) showed that only 2 of 7 NPA samples were positive for hMPV by culture; 2 of the 5 remaining samples were positive for influenza A, which may have masked the cytopathic effects of hMPV on rhesus monkey kidney (LLC-MK2) cells.</p>
    <fig id="F1" fig-type="figure" position="float">
      <label>Figure</label>
      <caption>
        <p>A) Phylogenetic analysis of human metapneumovirus (hMPV) strains isolated during an 11-month period based on nucleotide sequences of the G gene. Multiple nucleotide sequence alignments were performed by using the ClustalW program (<ext-link ext-link-type="uri" xlink:href="http://www.molecularevolution.org/cdc/software/clustalw">www.molecularevolution.org/cdc/software/clustalw</ext-link>); a phylogenetic tree was constructed with MEGA 3.1 software (<ext-link ext-link-type="uri" xlink:href="http://www.megasoftware.net">www.megasoftware.net</ext-link>) by using the neighbor-joining algorithm with Kimura-2 parameters. The analysis included the following hMPV reference strains: Can98/75 (GenBank accession no. AY485245), NL1/94 (AY304362), NL1/99 (AY304361), NL1/00 (AF371337), NL17/00 (AY304360), and Can97/83 (AY485253). Scale bar indicates 1 substitution for every 10 nucleic acid residues. <bold>Boldface</bold> indicates reference isolates. B) Comparison of the partial amino acid sequences (residues 26&#x2013;236) of the G protein of hMPV isolates recovered during an 11-month period from an immunocompromised child. Asterisks denote identical residues; shaded boxes highlight different amino acids between the hMPV variant of November 4, 2005, and the subsequent variants from January 20, 2006, to October 4, 2006.</p>
      </caption>
      <graphic xlink:href="07-1459-F"/>
    </fig>
    <p>Persistent hMPV infection in asymptomatic adult HSCT recipients has been described (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>). In that study, hMPV was isolated from 2 patients in 2 consecutive samples collected 12&#x2013;56 days apart. However, virus evolution was not adequately investigated because it was based on sequence analysis of a 150-bp fragment from the highly conserved nucleoprotein gene (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>). Unlike in previous reports (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>,<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>), characterization of hMPV strains in our study was performed by sequence analysis of a 633-bp fragment from the most variable hMPV G gene. Our findings showed 2 distinct hMPV variants of the same genotype (B2). These variants might represent a viral drift after immune pressure but most likely was the result of 2 different infections in the immunocompromised child. The latter hypothesis is suggested by the considerable amino acid variability (15 aa differences in the 211-aa region of the G protein) between strains collected on November, 4, 2005, and January, 20, 2006, compared with identical sequences for the strains recovered over the next 10 months. Debiaggi et al. (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>) previously suggested that persistent hMPV infection in HSCT patients was attributable to their inability to clear the virus because of impaired immune response. By contrast, adult lung transplant recipients were found to be able to achieve hMPV clearance despite their severe immunosuppression status (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>). Because both fatal and mild or asymptomatic hMPV infections have been reported in immunocompromised hosts, additional studies are needed to determine whether such differing outcomes are due to viral, host, or environmental factors. In conclusion, this case of persistent hMPV infection associated with relatively mild respiratory symptoms in an immunocompromised child suggests that the host&#x2019;s immune response may play a key role in disease pathogenesis.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Abed Y, Boivin G. Persistent human metapneumovirus infection in immunocompromised child [letter]. Emerg Infect Dis [serial on the Internet]. 2008 May [<italic>date cited</italic>]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/eid/content/14/5/854.htm">http://www.cdc.gov/eid/content/14/5/854.htm</ext-link></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <citation citation-type="journal"><string-name><surname>Abed</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Boivin</surname> <given-names>G</given-names></string-name> <article-title>Treatment of respiratory viral infections.</article-title><source>Antiviral Res</source> <year>2006</year>;<volume>70</volume>:<fpage>1</fpage>&#x2013;<lpage>16</lpage> <pub-id pub-id-type="doi">10.1016/j.antiviral.2006.01.006</pub-id><pub-id pub-id-type="pmid">16513187</pub-id></citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <citation citation-type="journal"><string-name><surname>Hamelin</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Abed</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Boivin</surname> <given-names>G</given-names></string-name> <article-title>Human metapneumovirus: a new player among respiratory viruses.</article-title><source>Clin Infect Dis</source> <year>2004</year>;<volume>38</volume>:<fpage>983</fpage>&#x2013;<lpage>90</lpage> <pub-id pub-id-type="doi">10.1086/382536</pub-id><pub-id pub-id-type="pmid">15034830</pub-id></citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <citation citation-type="journal"><string-name><surname>Pelletier</surname> <given-names>G</given-names></string-name>, <string-name><surname>D&#xE9;ry</surname> <given-names>P</given-names></string-name>, <string-name><surname>Abed</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Boivin</surname> <given-names>G</given-names></string-name> <article-title>Respiratory tract reinfections by the new human <italic>Metapneumovirus</italic> in an immunocompromised child.</article-title><source>Emerg Infect Dis</source> <year>2002</year>;<volume>8</volume>:<fpage>976</fpage>&#x2013;<lpage>8</lpage><pub-id pub-id-type="pmid">12194777</pub-id></citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <citation citation-type="journal"><string-name><surname>Cane</surname> <given-names>PA</given-names></string-name>, <string-name><surname>van den Hoogen</surname> <given-names>BG</given-names></string-name>, <string-name><surname>Chakrabarti</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fegan</surname> <given-names>CD</given-names></string-name>, <string-name><surname>Osterhaus</surname> <given-names>AD</given-names></string-name> <article-title>Human metapneumovirus in a hematopoietic stem cell transplant recipient with fatal lower respiratory tract disease.</article-title><source>Bone Marrow Transplant</source> <year>2003</year>;<volume>31</volume>:<fpage>309</fpage>&#x2013;<lpage>10</lpage> <pub-id pub-id-type="doi">10.1038/sj.bmt.1703849</pub-id><pub-id pub-id-type="pmid">12621469</pub-id></citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <citation citation-type="journal"><string-name><surname>Englund</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Boeckh</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kuypers</surname> <given-names>J</given-names></string-name>, <string-name><surname>Nichols</surname> <given-names>WG</given-names></string-name>, <string-name><surname>Hackman</surname> <given-names>RC</given-names></string-name>, <string-name><surname>Morrow</surname> <given-names>RA</given-names></string-name>, <etal/><article-title>Fatal human metapneumovirus infection in stem-cell transplant recipients.</article-title><source>Ann Intern Med</source> <year>2006</year>;<volume>144</volume>:<fpage>344</fpage>&#x2013;<lpage>9</lpage><pub-id pub-id-type="pmid">16520475</pub-id></citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <citation citation-type="journal"><string-name><surname>Debiaggi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Canducci</surname> <given-names>F</given-names></string-name>, <string-name><surname>Sampaolo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Marinozzi</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Parea</surname> <given-names>M</given-names></string-name>, <string-name><surname>Terulla</surname> <given-names>C</given-names></string-name>, <etal/><article-title>Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients.</article-title><source>J Infect Dis</source> <year>2006</year>;<volume>194</volume>:<fpage>474</fpage>&#x2013;<lpage>8</lpage> <pub-id pub-id-type="doi">10.1086/505881</pub-id><pub-id pub-id-type="pmid">16845630</pub-id></citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <citation citation-type="journal"><string-name><surname>Larcher</surname> <given-names>C</given-names></string-name>, <string-name><surname>Geltner</surname> <given-names>C</given-names></string-name>, <string-name><surname>Fischer</surname> <given-names>H</given-names></string-name>, <string-name><surname>Nachbaur</surname> <given-names>D</given-names></string-name>, <string-name><surname>Muller</surname> <given-names>LC</given-names></string-name>, <string-name><surname>Huemer</surname> <given-names>HP</given-names></string-name> <article-title>Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology.</article-title><source>J Heart Lung Transplant</source> <year>2005</year>;<volume>24</volume>:<fpage>1891</fpage>&#x2013;<lpage>901</lpage> <pub-id pub-id-type="doi">10.1016/j.healun.2005.02.014</pub-id><pub-id pub-id-type="pmid">16297797</pub-id></citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <citation citation-type="journal"><string-name><surname>Baz</surname> <given-names>M</given-names></string-name>, <string-name><surname>Abed</surname> <given-names>Y</given-names></string-name>, <string-name><surname>McDonald</surname> <given-names>J</given-names></string-name>, <string-name><surname>Boivin</surname> <given-names>G</given-names></string-name> <article-title>Characterization of multidrug-resistant influenza A/H3N2 viruses shed during one year by an immunocompromised child.</article-title><source>Clin Infect Dis</source> <year>2006</year>;<volume>43</volume>:<fpage>1555</fpage>&#x2013;<lpage>61</lpage> <pub-id pub-id-type="doi">10.1086/508777</pub-id><pub-id pub-id-type="pmid">17109288</pub-id></citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <citation citation-type="journal"><string-name><surname>Ludewick</surname> <given-names>HP</given-names></string-name>, <string-name><surname>Abed</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Van Niekerk</surname> <given-names>N</given-names></string-name>, <string-name><surname>Boivin</surname> <given-names>G</given-names></string-name>, <string-name><surname>Klugman</surname> <given-names>KP</given-names></string-name>, <string-name><surname>Madhi</surname> <given-names>SA</given-names></string-name> <article-title>Human metapneumovirus genetic variability, South Africa.</article-title><source>Emerg Infect Dis</source> <year>2005</year>;<volume>11</volume>:<fpage>1074</fpage>&#x2013;<lpage>8</lpage><pub-id pub-id-type="pmid">16022783</pub-id></citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <citation citation-type="journal"><string-name><surname>Boivin</surname> <given-names>G</given-names></string-name>, <string-name><surname>Abed</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Pelletier</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ruel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Moison</surname> <given-names>D</given-names></string-name>, <string-name><surname>C&#xF4;t&#xE9;</surname> <given-names>S</given-names></string-name>, <etal/><article-title>Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups.</article-title><source>J Infect Dis</source> <year>2002</year>;<volume>186</volume>:<fpage>1330</fpage>&#x2013;<lpage>4</lpage> <pub-id pub-id-type="doi">10.1086/344319</pub-id><pub-id pub-id-type="pmid">12402203</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
